Concepedia
Statistics
Publications
4
Citations
95
H-Index
Active since
2009
Affiliations
Pfizer (Japan)(Current)
Pfizer (United States)
Yinhua Li is an author at Pfizer (Japan) specializing in medicine, malignant tumors, and oncology.
Publications per year
2009–2021
Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate
Kuniaki Shirao, Toshirou Nishida, Toshihiko Doi et al. · Investigational New Drugs · 2009 · 64 citations
Medicine, Oncology, Pharmacotherapy +15
Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn’s disease in Japanese and Korean patients: the OPERA study
Masayuki Saruta, Dong Il Park, Young‐Ho Kim et al. · Intestinal Research · 2020 · 11 citations · Full text
Life Sciences, Immunology, Pharmacology +17
Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects
Yinhua Li, Yuting Mu, Haihong Shi et al. · Clinical Pharmacology in Drug Development · 2019 · 10 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +16
Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Healthy Japanese and Western Subjects
Yinhua Li, Gianluca Nucci, Yuichi Yamamoto et al. · Clinical Pharmacology in Drug Development · 2021 · 10 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +14
1–4 of 4